No article text was recorded for this version.
longitudinal genomic profiling
Version 1 of 118 papers21 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel
- Blog: The Essentials of Multiomics
- Blog: Integrated circulating tumor DNA-based prognostic algorithm for limited stage small-cell lung cancer under definitive chemoradiotherapy and utility in consolidation immunotherapy benefit prediction
- Blog: Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series
- Blog: HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment
- Blog: Case report: Acute pancreatitis in lung adenocarcinoma with small cell transformation after multiple line targeted therapy
- Blog: Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial
- Blog: SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment
- Blog: Circulating tumor <scp>DNA</scp> for prognosis assessment and postoperative management after curative‐intent resection of colorectal liver metastases
- Blog: Isolation and characterization of circulating tumor cells in prostate cancer
- Blog: Multiparametric Circulating Tumor Cell Analysis to Select Targeted Therapies for Breast Cancer Patients
- Blog: Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial
- Blog: Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
- Blog: Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma
- Blog: Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
- Blog: ctDNA in Pancreatic Adenocarcinoma: A Critical Appraisal
- Blog: Endometrioid carcinomas with sex cord-like formations and hyalinization: spontaneous pregnancy after conservative treatment
- Blog: On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_longitudinal_genomic_profiling_18f1bf70,
title = {longitudinal genomic profiling},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/longitudinal-genomic-profiling/rdr_18f1bf70d19b4c8ca9c5026a7e892c70},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-22},
}This exact version (version 1, frozen text):
@misc{lacuna_longitudinal_genomic_profiling_18f1bf70_v1,
title = {longitudinal genomic profiling},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/longitudinal-genomic-profiling/rdr_18f1bf70d19b4c8ca9c5026a7e892c70/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-22},
}